Abstract

sites KEY PERSONNEL. See Instructions. Use continuation pages es needed to provide the required information in the format sfiown below. Start with Principal Investigator. list all other key personnel in alphabetical order, last name first. Name Organization Role on Project Myron D. Ginsberg, M.D. University of Miami School of Medicine Principal Investigator Michael D. Hill, M.D., M.Sc. University of Calgary, Alberta, Canada Co-Principal Investigator Yuko Y. Palesch, Ph.D. Medical Univ. of S. Carolina, Charleston Co-Principal Investigator Renee H. Martin, Ph.D. Medical Univ. of S. Carolina, Charleston ProjectCoordinator Wenle Zhao, Ph.D. Medical Univ. of S. Carolina, Charleston Co-Investigator Catherine R. Dillon, B.S. .Medical Univ. of S. Carolina, Charleston Manager, Data Management Diego Tamariz, M.D. University of Miami School of Medicine Assistant to P.I. Karla J. Ryckborst, B.A., R.N. University of Calgary, Alberta, Canada Nurse Coordinator Disclosure Permistlon Statement. Applicable toSBIRfSTTR. Only. See instrudions. (~1 Yes S No PHS 398 (Rev. 05/01) Pag* 2 Number page* eoniecutivcly at tn?Bottom througnwl Form Pago 2 th? application. Do not UMI auTixfci ?uch 88 2fl. 2b.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01NS054630-02
Application #
7121177
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Gilbert, Peter R
Project Start
2005-09-15
Project End
2010-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
2
Fiscal Year
2006
Total Cost
$1,421,303
Indirect Cost

  Institution

Name
Medical University of South Carolina
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425

  Publications

Fan, Liqiong; Yeatts, Sharon D; Wolf, Bethany J et al. (2018) The impact of covariate misclassification using generalized linear regression under covariate-adaptive randomization. Stat Methods Med Res 27:20-34
Nowacki, Amy S; Zhao, Wenle; Palesch, Yuko Y (2017) A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials. Stat Methods Med Res 26:1078-1092
Martin, Renee' H; Yeatts, Sharon D; Hill, Michael D et al. (2016) ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke 47:2355-9
Lees, Kennedy R; Selim, Magdy H; Molina, Carlos A et al. (2016) Early Versus Late Assessment of Stroke Outcome. Stroke 47:1416-9
Weng, Yanqiu; Palesch, Yuko Y; DeSantis, Stacia M et al. (2016) Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rate. J Biopharm Stat 26:672-85
Adeoye, Opeolu; Sucharew, Heidi; Khoury, Jane et al. (2015) Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke 46:461-4
Broderick, Joseph P; Berkhemer, Olvert A; Palesch, Yuko Y et al. (2015) Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Stroke 46:3416-22
Zhao, Wenle; Mu, Yunming; Tayama, Darren et al. (2015) Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies. Contemp Clin Trials 41:211-8
Menon, Bijoy K; Qazi, Emmad; Nambiar, Vivek et al. (2015) Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial. Stroke 46:1239-44
Palesch, Yuko Y; Yeatts, Sharon D; Tomsick, Thomas A et al. (2015) Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke 46:1321-7

Showing the most recent 10 out of 48 publications